Current role
Packaged Foods · Consumer Defensive
CFO, Chief Accounting Officer
2024-07-13–present
James Lee
Chief Accounting Officer
Niagen Bioscience, Inc. (NAGE)Equibles does not estimate personal net worth.
Get an email with a short summary when Niagen Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get NAGE alertsAbout James Lee
James Lee is recorded as Chief Accounting Officer at Niagen Bioscience, Inc. (NAGE) since July 13, 2024 and CFO at Niagen Bioscience, Inc. (NAGE). Niagen Bioscience, Inc. reported in an 8-K filed July 16, 2024 that James Lee was appointed Interim Principal Accounting Officer, effective July 13, 2024. Niagen Bioscience, Inc. reported in an 8-K filed July 16, 2024 that James Lee was appointed Interim Chief Financial Officer and Interim Principal Accounting Officer, effective July 13, 2024. The proxy statement of Niagen Bioscience, Inc. reports total compensation of $374,470 for James Lee in fiscal 2024, including a base salary of $228,462. Niagen Bioscience, Inc. is classified in the Packaged Foods industry within the Consumer Defensive sector. Other leadership on record at Niagen Bioscience, Inc. includes Robert Fried (CEO and Board Member), Frank Jaksch (Chairman and Board Member), Ozan Pamir (CFO and Chief Accounting Officer) and 7 others.
“On July 16, 2024, the Board of Directors (the "Board") of ChromaDex Corporation (the "Company" or "ChromaDex") appointed James Lee, the Company's current Controller, as the Company's Interim Chief Financial Officer and Interim Principal Accounting Officer, effective as of July 13, 2024.”
“On July 16, 2024, the Board of Directors (the "Board") of ChromaDex Corporation (the "Company" or "ChromaDex") appointed James Lee, the Company's current Controller, as the Company's Interim Chief Financial Officer and Interim Principal Accounting Officer, effective as of July 13, 2024.”
Affiliation history
-
Current
2024-07-13–present
-
Current
Company network
Leadership on record at Niagen Bioscience, Inc.
- Robert Fried CEO, Board Member
- Frank Jaksch Chairman, Board Member
- Ozan Pamir CFO, Chief Accounting Officer
- Carlos Lopez General Counsel
- Ann Cohen Board Member
- Caroline S. Levy Board Member
- Frank L. Jaksch Jr. Board Member
- Frank L. Jaksch, Jr. Board Member
- Gary Ng Board Member
- Hamed Shahbazi Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Niagen Bioscience, Inc. (NAGE) | Controller, Former Interim Chief Financial Officer | $228,462 | $374,470 |